Survenus - A battle tested early warning system for epidemics

The first line of defense against epidemics - Forecasting public health emergencies years before they emerge

Mauro Peixe, Founder & CEO

In 2019, Malaria alone infected more than 3% of the world's population. Infectious diseases represent one of the leading causes of mortality and their outbreak proneness presents catastrophic consequences to worldwide economies, as demonstrated by the 15% GDP reduction suffered by Sierra Leone, during the 2014-2016 Ebola outbreak.

After centuries with consecutive severe disease outbreaks, not much progress has been achieved. Humanity still faces challenges quantifying diseases impact, let alone be able to predict and identify public health emergencies with sufficient anticipation.

The combination of scarce, inconsistent and non-standardised data available, the inefficient surveillance systems lacking prediction and analytical capabilities about situational evolution, the lack of citizen observations integration and a deficient dissemination of findings contributed once more for the inability to avoid a new large scale epidemic, something becoming increasingly recurrent during the last decades.

We provide the tools governments, businesses and citizens need to overcome their daily challenges and improve decision-making processes.

1) Governments need access to early warnings on emerging public health emergencies to be able to implement efficient prevention policies and procedures that assure citizen health and safety.

2) Businesses need access to early warnings and granular health data to quantify epidemic risk within their operations, investments, supply chains, services and products.

3) Citizens needs access to properly validated and easy to understand epidemic information around their location, specially when travelling.

Survenus was developed from inception in close partnership with our target audiences, including the insurance industry. Several field trials and pilots were performed during the development of Survenus, with organisations and currently with current beta testers of the Mobile app.

We believe that proper education and information are key to ensure citizen safety and trust. Through our free mobile app, worldwide citizens will be able to receive real-time curated information on relevant public health matters around their location or destination, which include current disease outbreaks, local procedures implemented and official news, enabling citizens to be better prepared and informed.

Survenus evens the combat against infectious diseases that humanity has been losing for centuries. Being able to predict the future will help save lives and create more resilient societies and economies. An example is a farming company we have been working, which was able to reduce the losses from Covid-19 lockdowns by diverting some of its production to their national market, after receiving the forecasts that indicated the second waves of infections in its international markets, reducing losses by 70%.

We are empowering a society where everyone will have access to information to protect themselves and everyone around them, without any sort of discrimination.

To scale the adoption of our commercial offering (Platform and API) we intend to further develop our partner network. We seek partnerships with software distributors, integrators and value-added resellers to be able to accelerate the growth of Survenus, by using a share revenue model.

For our free app, we will partner with public agencies and other organisations to increase its visibility and dissemination close to citizens. Over the next year we aim to

To help us achieve these ambitious goals, we are currently seeking to close a financing round.

For our commercial offering we currently measure number of customers, monthly recurrent revenue, churn.

For our free mobile app, as a starting point, we intend to measure the number of installs, churn and the number of daily and monthly active.

NVIDIA (www.nvidia.com)

Plug and Play Tech Center (www.plugandplaytechcenter.com)

InsurLab Germany (www.insurlab-germany.com)

The Trinity Challenge is one of the most important innovation actions within the public health space. The positioning and relevance of the promoting organisations have the power to open doors and accelerate the growth and impact of Survenus at a pace and scale, not possible otherwise.

Through the introduction to relevant entities and organisations, media exposure, technical and economic support or simply the use of our products, the Trinity Challenge is just an opportunity that we could not waste.

We believe that all partners can help Survenus to accelerate its impact, weather it is by connecting Survenus with potential customers or official authorities, support us in our go-to-market or simply be end users of our offering. The list includes Aviva, Bill & Melinda Gates Foundation, Brunswick, Discovery, GSK, Insitute for Health Metrics and Evaluation, McKinsey & company, Optum, Patric J McGovern Foundation, BD, SwissRE.